论文部分内容阅读
目的:观察噻托溴铵,普米克令及万托林治疗老年慢性阻塞性肺气肿加重期的临床效果。方法:选取2015年6月~2016年6月我院收治的74例患者为研究对象,随机分为两组,各37例,对照给予常规治疗,在此基础上,研究组给予噻托溴铵,普米克令及万托林治疗,对比两组患者治疗效果。结果:研究组的治疗总有效率、治疗满意率均高于对照组,差异显著;研究组的肺功能指标、血气分析指标及时间指标均优于对照组,差异显著。结论:噻托溴铵,普米克令及万托林治疗老年慢性阻塞性肺气肿加重期,疗效确切,值得推广。
Objective: To observe the clinical effects of tiotropium, pulmicort and vtoparin in the treatment of senile chronic obstructive pulmonary emphysema. Methods: Totally 74 patients admitted to our hospital from June 2015 to June 2016 were selected and randomly divided into two groups (n = 37 in each group). The control group was given routine treatment. On the basis of this, the study group was given tiotropium , Pulmicort and Wan Velin treatment, compared the treatment effect of two groups of patients. Results: The total effective rate and the satisfaction rate of treatment in study group were higher than those in control group, and the difference was significant. The pulmonary function index, blood gas analysis index and time index in study group were better than those in control group, with significant difference. Conclusion: Tiotropium bromide, pulmicortin and vetolin in the treatment of senile chronic obstructive pulmonary emphysema exacerbation, the exact effect, it is worth promoting.